Kuros Biosciences AG (SWX:KURN)

Market Cap	729.60M
Revenue (ttm)	75.56M
Net Income (ttm)	-4.29M
Shares Out	37.96M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	121,237
Average Volume	207,141
Open	18.66
Previous Close	19.22
Day's Range	18.06 - 19.20
52-Week Range	5.76 - 32.00
Beta	0.70
RSI	37.01
Earnings Date	Mar 14, 2025

About Kuros Biosciences AG

Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 122
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: KURN

Financial Performance

In 2024, Kuros Biosciences AG's revenue was 75.56 million, an increase of 125.11% compared to the previous year's 33.56 million. Losses were -4.29 million, -68.75% less than in 2023.